IT DEPENDS ON YOUR PLAN
Does TRICARE Cover Zepbound?
Coverage Changed in August 2025
TRICARE coverage for Zepbound now depends entirely on which plan you have. TRICARE Prime, Select, and related plans still cover Zepbound with prior authorization. TRICARE For Life beneficiaries lost coverage on August 31, 2025.[1]
TRICARE coverage for Zepbound splits into three categories as of November 2025:
| TRICARE Plan | Zepbound for Weight Loss | Status | Notes |
|---|---|---|---|
| Prime | Covered with PA | Active | Step therapy + PA required |
| Prime Remote | Covered with PA | Active | Step therapy + PA required |
| Select | Covered with PA | Active | Step therapy + PA required |
| Young Adult | Covered with PA | Active | Step therapy + PA required |
| Reserve Select | Covered with PA | Active | Step therapy + PA required |
| Retired Reserve | Covered with PA | Active | Step therapy + PA required |
| US Family Health Plan | Covered with PA | Active | Step therapy + PA required |
| CHCBP (Continued Health Care Benefit Program) | Covered with PA | Active | Step therapy + PA required |
| TRICARE For Life (TFL) | NOT Covered | Ended 8/31/25 | Policy exclusion; diabetes GLP-1s still covered |
| Direct Care Only | NOT Covered | Ended 8/31/25 | MTF access without plan enrollment |
Key takeaway: If you have TRICARE Prime, Select, or related plans, Zepbound IS covered—but you'll need to navigate prior authorization (PA, where your doctor must get approval before you can fill the prescription) and step therapy (trying lower-cost medications first). If you have TRICARE For Life, weight loss drug coverage ended August 31, 2025.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
WHAT HAPPENED TO TRICARE FOR LIFE?
The August 2025 Policy Change
TFL Coverage Ended August 31, 2025
On August 31, 2025, the Defense Health Agency (DHA) implemented "regulatory controls" that ended weight loss medication coverage for TRICARE For Life beneficiaries and those with direct care only.[1][2]
What Changed
DHA's official statement: "TRICARE has been providing coverage for weight loss medications to beneficiaries who were not eligible under federal statute. This implementation corrects that unauthorized coverage."[2]
This means:
- Even if you had an approved PA before August 31, it became invalid on that date
- You now pay 100% out of pocket for Wegovy, Zepbound, Saxenda, Qsymia, Phentermine, and Contrave if prescribed for weight loss
- No grandfathering—the change applied immediately to all TFL beneficiaries
What's Still Covered for TFL
Diabetes Indication Still Covered
GLP-1s prescribed for Type 2 diabetes (Ozempic, Mounjaro, Victoza) remain covered for TFL beneficiaries with prior authorization. If you have diabetes, speak with your provider about whether these medications are appropriate.[1]
Advocacy Response
The Military Officers Association of America (MOAA) has challenged this change, arguing it:
- Creates "two classes of drug coverage" between TRICARE and TFL beneficiaries
- Sets a dangerous precedent for future benefit reductions
- Lacks clear statutory basis—MOAA found no federal statute specifically excluding TFL from GLP-1 coverage[1]
The advocacy effort is ongoing, but no immediate reversal is expected. TFL beneficiaries should explore alternatives (see Options if TRICARE Won't Cover).
TFL vs. Standalone Medicare
TRICARE For Life is NOT the same as standalone Medicare. TFL is a federal TRICARE plan that wraps around Medicare for military retirees. Basic Medicare Part D coverage also excludes drugs used for weight loss, but TFL beneficiaries with Medicare Part D may be able to use the separate Medicare GLP-1 Bridge, which runs outside the Part D benefit (Zepbound KwikPen only, $50 per monthly fill, with conditions). TFL and Medicare have separate rules and appeals processes. For Medicare-specific coverage details, see our Medicare coverage guide.
TRICARE PRIME & SELECT
How to Get Zepbound Approved
For eligible TRICARE plans (Prime, Select, Young Adult, Reserve Select, Retired Reserve, US Family Health Plan, CHCBP), Zepbound IS covered—but you must clear multiple hurdles.
Prior Authorization Requirements
Your provider must submit the Express Scripts PA form certifying:
| Requirement | TRICARE Criteria | Notes |
|---|---|---|
| Age | 18+ (adults only) | Zepbound is FDA-approved for adults only |
| BMI Threshold | ≥30, or ≥27 with comorbidity | Matches FDA indication |
| Qualifying Comorbidities | Hypertension, dyslipidemia, sleep apnea, metabolic dysfunction | Must have ICD-10 codes documented |
| Lifestyle Documentation | 6 months diet/exercise that failed | Must be documented, not just attested |
| Step Therapy | Must fail 1 preferred drug | Phentermine, Qsymia, Saxenda, or Contrave |
| Ongoing Lifestyle | Must continue behavioral modification | Reduced-calorie diet throughout therapy |
| No Contraindications | No MTC (medullary thyroid cancer), MEN2 (multiple endocrine neoplasia), pancreatitis, eating disorders | Uncontrolled hypertension also excluded |
| Initial Approval | 12 months | Renewal requires ≥5% weight loss |
PA Documentation Checklist
Required for TRICARE Zepbound Approval
- Current height and weight (within last 30 days)
- BMI calculation documented by provider
- 6-month lifestyle modification—actual documentation of diet/exercise program with insufficient weight loss
- Proof of step therapy—documented trial and failure (or contraindications) of at least one preferred drug
- Comorbidity diagnoses with ICD-10 codes:
- Obesity Class I (E66.811), Class II (E66.812), Class III (E66.813)
- Hypertension (I10)
- Dyslipidemia (E78.5)
- Obstructive Sleep Apnea (G47.33)
- No contraindications—confirmation of no MTC, MEN2, pancreatitis history
- Provider-completed Express Scripts PA form
denied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
WHAT TRICARE REQUIRES FIRST
Step Therapy Requirements
TRICARE enforces step therapy, meaning you must try less expensive, preferred medications before stepping up to Zepbound.[3]
| Drug | Form | Why TRICARE Requires It First | Common Issues |
|---|---|---|---|
| Phentermine | Oral tablet | More affordable, established, well-studied | Insomnia, elevated BP, anxiety |
| Qsymia | Oral capsule | Combination therapy, modest efficacy | Cognitive effects, increased HR |
| Saxenda | Daily injection | GLP-1 agonist, less potent than Zepbound | Daily injections, GI side effects |
| Contrave | Oral tablet | Unique mechanism, lower cost | Nausea, elevated BP |
Step Therapy Exception
If you've tried and failed a preferred drug in the last 180 days, or have documented contraindications to all preferred drugs, you may qualify for Zepbound without repeating step therapy.[3]
How to Document Step Therapy Failure
For your step therapy to count, your medical record must show:
- Drug name and dates of the trial period
- Duration (typically 3+ months adequate trial)
- Outcome—insufficient weight loss (<5%) or intolerable side effects
- Reason for discontinuation documented by provider
For more on navigating step therapy requirements, see our step therapy guide.
AN ALTERNATIVE PATHWAY
Sleep Apnea Coverage
OSA Indication May Bypass Step Therapy
Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity (approved December 20, 2024). This is a separate indication from weight loss and may have different coverage requirements.[4]
OSA Coverage Requirements
- Sleep study documenting AHI ≥15—that's your apnea-hypopnea index, the number of breathing interruptions per hour of sleep
- BMI ≥30
- No step therapy requirement for OSA indication (this is key—may bypass phentermine/Saxenda trial)
- Same contraindications apply (medullary thyroid cancer, pancreatitis, etc.)
Why This Matters
If you have diagnosed moderate-severe sleep apnea, you may qualify for Zepbound without needing to fail other weight loss drugs first. This pathway is particularly valuable if:
- You've had side effects from preferred drugs
- You want to skip the step therapy process
- Your primary concern is sleep apnea management
TFL and OSA Coverage
For TRICARE For Life beneficiaries, Zepbound for OSA is not covered through TRICARE. TFL follows Medicare rules, and the August 2025 policy change applies to all weight-related indications. However, TFL beneficiaries should check if their Medicare Part D plan separately covers Zepbound for OSA or cardiovascular risk reduction—some Part D plans may cover GLP-1s for non-obesity indications.[4][11]
Don't have a sleep apnea diagnosis? If you have symptoms like snoring, daytime sleepiness, or witnessed breathing pauses, ask your doctor about a sleep study. An AHI score ≥15 could open this coverage pathway.
TRICARE ZEPBOUND COPAYS
What You'll Pay
Zepbound is a non-formulary brand-name drug on the TRICARE formulary. Copays vary by point of service.[5]
| Point of Service | 2025 Copay | 2026 Copay | Notes |
|---|---|---|---|
| Military Pharmacy (MTF) | $0 | $0 | Generally not stocked for non-formulary |
| TRICARE Home Delivery (90-day) | $76 | $85 | Best value for maintenance fills |
| Retail Network (30-day) | $76 | $85 | Same as home delivery for non-formulary |
| Non-Network Pharmacy | 20-50% cost-share | 20-50% cost-share | After deductible; full pay upfront, then reimbursement |
Active Duty Service Members
$0 copay at all points of service—military pharmacies, retail network, and home delivery. Active duty copays remain unchanged in 2026.[5]
Without Coverage
If you're a TFL beneficiary or otherwise don't have coverage:
- List price: about $1,086/month
- LillyDirect: $299–$449/month (tiered by dose)
- TrumpRx.gov: TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price) (for Zepbound, the LillyDirect price)
- See self-pay alternatives for more options
EXPRESS SCRIPTS PROCESS
How to Submit Your PA
Search TRICARE Formulary
Go to the TRICARE Formulary Search Tool and search "Zepbound" to confirm coverage status and download the PA form.
Download the PA Form
Download the "TRICARE Prior Authorization Request Form for Wegovy, Zepbound" (tirzepatide injection form).
Provider Completes Form
Your prescriber must fill out clinical assessment questions including BMI, prior treatments, comorbidities, and step therapy documentation.
Submit to Express Scripts
- Phone: 1-866-684-4488
- Fax: 1-866-684-4477
- Email: TPharmPA@express-scripts.com
- Mail: Express Scripts, P.O. Box 52150, Phoenix, AZ 85072-9954
Wait for Determination
Typically ~10 days after Express Scripts receives the complete form. Initial approvals are for 12 months.[6]
Active Duty Note
Even if coverage will not be approved, the PA form must initially be submitted to Express Scripts. Subsequent reconsideration is allowed at your Military Treatment Facility.[3]
COMMON TRICARE DENIAL REASONS
Why Your Claim Was Denied
| Denial Reason | What It Means | How to Fix |
|---|---|---|
| Plan exclusion (TFL/direct care) | You're on TRICARE For Life or direct care only—weight loss drugs ended Aug 31, 2025 | Appeal unlikely to succeed; check Medicare Part D for OSA coverage or consider cash pay |
| Step therapy not met | No documented trial and failure of Phentermine, Qsymia, Saxenda, or Contrave | Document trial and failure of at least one preferred drug |
| BMI too low | BMI <27, or BMI 27-29 without documented comorbidity | Document comorbid conditions (hypertension, dyslipidemia, sleep apnea) |
| Insufficient lifestyle documentation | No proof of 6-month diet/exercise trial | Provide weight logs, dietitian notes, exercise records |
| Missing diagnosis code | Prescription didn't include medically accepted indication | Ensure provider submits with correct ICD-10 for obesity or OSA |
| Contraindication flagged | History of MTC, pancreatitis, eating disorder in records | Provide updated records showing contraindication resolved or misapplied |
Understanding your specific denial reason is critical for a successful appeal. Request the denial in writing with the exact reason code.
TRICARE PHARMACY APPEALS
How to Appeal
Filing Your Appeal
You have 90 days from the denial notice postmark to submit a pharmacy appeal to Express Scripts.[7]
Why Fight for Coverage?
Win your appeal → pay your TRICARE copay ($85 for a non-formulary drug in 2026; $0 for active duty). Lilly's savings card can't be used with TRICARE. Without TRICARE coverage, you'd pay $299–$449/month (LillyDirect; TrumpRx lists the same prices). That's hundreds of dollars in monthly savings — worth the fight.
What to Include in Your Appeal
- Written, signed appeal letter explaining why you disagree
- Copy of the denial decision from Express Scripts
- Supporting documentation addressing the specific denial reason
- Letter of Medical Necessity from your prescriber
- Updated medical records (weight, BMI, comorbidities)
- Clinical evidence—SURMOUNT trial data showing 15-21% weight loss
Where to Send Your Appeal
Express Scripts Appeal Address
Mail: Express Scripts, Inc., P.O. Box 60903, Phoenix, AZ 85082-0903
Fax: Use the number on your denial letter
Phone (questions): 1-877-363-1303
Appeal Timeframes
- Standard appeal: Decision within 30 days
- Expedited appeal: 72 hours (if urgent medical need documented by provider)
- Second level appeal: If first appeal denied, you can request further review
Realistic Expectations
| Denial Type | Appeal Likelihood | Why |
|---|---|---|
| Procedural (missing docs, step therapy) | Good success rate | If you provide the missing evidence, criteria can be met |
| Plan exclusion (TFL policy) | Very low success rate | DHA position is this is statutory/regulatory, not case-by-case |
For detailed appeal strategies, see our complete Zepbound appeals guide.
YOUR OPTIONS
If TRICARE Won't Cover
If you're facing a denial or exclusion, here are your options:
1. LillyDirect Cash Pay
- $299–$449/month (tiered by dose: $299/2.5mg, $399/5mg, $449/7.5-15mg)
- No insurance required; includes telehealth visit and home delivery
- See our LillyDirect guide
2. TrumpRx.gov (Federal Program)
- TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price): for Zepbound, the LillyDirect price above (launched February 5, 2026)
- Available to anyone regardless of insurance status—no TRICARE needed
- Visit TrumpRx.gov
3. Foundayo (Oral GLP-1)
- $149–$299/month self-pay for Eli Lilly's oral GLP-1 (FDA approved April 1, 2026)
- Daily pill—no injections required
- See our Foundayo guide
5. Manufacturer Savings Card
- Lilly's savings card is for commercial insurance only: Not for Medicare, Medicaid, TRICARE, VA or other government insurance
- So it can't be used with any TRICARE plan, including TFL
- See our savings card guide
6. Diabetes-Indication Coverage
- If you have Type 2 diabetes, ask your provider about Mounjaro (same drug as Zepbound, different FDA indication)
- Mounjaro IS covered on TRICARE with PA for diabetes—even for TFL
7. Sleep Apnea Pathway
- If you have or can get diagnosed with moderate-severe OSA (AHI ≥15), pursue Zepbound under OSA indication
- For Prime/Select: OSA pathway often bypasses step therapy requirements (though handling can vary)
- For TFL: TRICARE does not cover, but check if your Medicare Part D plan covers Zepbound for OSA separately
8. Alternative GLP-1s
- Check if Wegovy or Saxenda have different formulary status
- Saxenda is a preferred drug on TRICARE—may have lower copay and easier approval
9. Professional Appeal Service
- Consider professional appeal writing services (like Honest Care) for complex denials
- Evidence-backed appeals with clinical citations
SPECIAL RULES
Active Duty Service Members
Zero Copay Benefit
Active duty service members pay $0 copay at military pharmacies, network retail pharmacies, and TRICARE Home Delivery—both in 2025 and 2026.[5]
Key Considerations for Active Duty
- Medical necessity required for non-formulary drugs including Zepbound
- Military Treatment Facility (MTF) formulary restrictions: Military pharmacies generally don't stock non-formulary drugs unless medically necessary
- Command requirements: May need to follow Military Department-specific policies for weight management programs
- PA process: Even if coverage will not be approved, PA form must be submitted to Express Scripts first; subsequent reconsideration allowed at your MTF
Fitness standards: If weight loss is related to meeting fitness standards, work with your unit's medical team to document medical necessity appropriately.
WHAT'S CHANGING
2026 Outlook
TRICARE's coverage split (Prime/Select covered, TFL excluded) is expected to remain through 2026. Non-formulary copays increase from $76 to $85 starting January 1, 2026.
New Options for TFL Beneficiaries (2026)
- TrumpRx.gov (launched February 5, 2026): lists Zepbound at the LillyDirect self-pay price ($299–$449/month)—no insurance needed
- Foundayo (FDA approved April 1, 2026): Oral GLP-1 at $149–$299/month self-pay
- Medicare GLP-1 Bridge: If you're enrolled in Medicare Part D (alongside TFL), the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers the Zepbound KwikPen for $50 per monthly fill with conditions; Part D plans and pharmacies don’t opt in, and you don’t enroll separately; your prescriber must get prior authorization
TRICARE For Life members: see our Medicare guide for 2026 policy updates that may affect your Part D coverage.
TRICARE ZEPBOUND COVERAGE
Frequently Asked Questions
It depends on your plan. TRICARE Prime, Select, Young Adult, Reserve Select, Retired Reserve, US Family Health Plan, and CHCBP cover Zepbound with prior authorization and step therapy. TRICARE For Life and direct care only beneficiaries lost coverage on August 31, 2025.
DHA implemented "regulatory controls" on August 31, 2025, stating TFL was covering weight loss drugs for beneficiaries "not eligible under federal statute." The change aligns TFL with Medicare's weight loss drug exclusion. MOAA has challenged this decision, but no reversal is expected in the near term.
For Prime/Select: Yes, potentially. Zepbound is FDA-approved for moderate-severe obstructive sleep apnea (OSA) in adults with obesity. An OSA prescription may be handled differently from a weight-loss prescription (for example, without the same step therapy requirements); check with TRICARE. For TFL: No. The August 2025 policy change excludes all weight-related indications. TFL beneficiaries should check if their Medicare Part D plan covers Zepbound for OSA separately.
You must try and fail (or have documented contraindications to) at least one of: Phentermine, Qsymia, Saxenda, or Contrave. If you've failed a preferred drug in the last 180 days, you may get automatic approval for Zepbound.
With approved coverage: $76 copay (2025) or $85 (2026, non-formulary) for 30-day retail or 90-day home delivery. Active duty service members pay $0 at all points of service. Without coverage (TFL, direct care): $299–$449/month via LillyDirect (TrumpRx.gov lists the same prices), or $149–$299/month for Foundayo (oral GLP-1).
Yes. You have 90 days from the denial postmark to submit a pharmacy appeal to Express Scripts. Procedural denials (missing step therapy, insufficient documentation) have good success rates if you provide the missing evidence. Plan exclusion denials (TFL policy) are very difficult to overturn.
TRICARE covers Mounjaro (same active ingredient as Zepbound—tirzepatide) for Type 2 diabetes with prior authorization. It's NOT covered for weight loss. If you have Type 2 diabetes, this may be an option even for TFL beneficiaries.
Approximately 10 days after Express Scripts receives the complete PA form. Initial approvals are for 12 months. Renewal requires documentation of ≥5% weight loss from baseline.
YOUR PATH FORWARD
What's Next
Zepbound Coverage: Other Insurance Options
Coverage varies significantly by program type. See our guides:
- Medicare — basic Part D coverage excludes drugs used for weight loss; the separate Medicare GLP-1 Bridge covers the Zepbound KwikPen (with conditions, including prior authorization)
- Medicaid — 13 states cover for obesity
- Blue Cross Blue Shield — Major 2026 coverage restrictions
- UnitedHealthcare — Coverage varies by plan
- Aetna — Most plans exclude; limited employer exceptions with PA
References
- MOAA. (2025). "Weight-Loss Drug Coverage Ends for TRICARE For Life Beneficiaries: What's Next?" moaa.org
- TRICARE Newsroom. (2025). "TRICARE Coverage of Weight Loss Medications: What To Know." tricare.mil
- GoodRx. (2025). "Does TRICARE Cover Wegovy and Zepbound?" goodrx.com
- TRICARE Newsroom. (2025). "Q&A: TRICARE For Life Coverage of Weight Loss Medications." tricare.mil
- Express Scripts. (2025). "Changes to your TRICARE prescription drug copayments in 2026." militaryrx.express-scripts.com
- TRICARE Newsroom. (2025). "Getting Prior Authorizations for TRICARE Prescriptions: Your Questions Answered." tricare.mil
- TRICARE. (2025). "Pharmacy Appeals." tricare.mil
- TRICARE. (2025). "Does TRICARE cover Wegovy, Ozempic, and Mounjaro?" tricare.mil
- TRICARE. (2025). "Weight Loss Products." tricare.mil
- Military Times. (2025). "Tricare to end coverage of weight-loss meds for some military retirees." militarytimes.com
- Express Scripts. (2026). "Are GLP-1 and weight loss medications covered through TRICARE Pharmacy?" militaryrx.express-scripts.com. Accessed January 2026.
Last updated October 6, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.